DAXXIFYTM (达克西博胺毒素A-Lanm) 用于注射,用于肌肉内使用
Aditya K Gupta1,2, Avantika Mann3, Kimberly Vincent4
1Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, Ontario, Canada.
达克西菲 (daxibotulinumtoxinA-lanm) 通过改善肌肉活动,有效地治疗中度至重度的肌线条. 临床试验表明,患者和研究人员在治疗后报告的纹严重程度有显著的改善.
科学领域:
- 皮肤病学 皮肤病学
- 神经学 神经学
- 审美学 在审美学方面
背景情况:
- 达克西菲 (daxibotulinumtoxinA-lanm) 是一种新的肉毒毒素A型配方.
- 它使用一种独特的助剂来增强神经元膜结合和潜在的更长的作用时间.
- 骨线 (GLs) 是由波纹体和/或前体肌肉活动引起的.
研究的目的:
- 为了评估达克西博胺毒素A注射剂 (DAXI) 的疗效和安全性,在成年人中,有中度至严重的 glabellar 线条.
- 建立DAXI作为治疗选择,以暂时改善 glabellar线条的外观.
主要方法:
- 进行了两项随机,双盲,安慰剂控制的第三期试验 (SAKURA 1和SAKURA 2).
- 主要终点:在第4周GL严重性改善≥2点的复合临床结果.
- 一项开放式的多周期研究 (SAKURA 3) 评估了较大人群的长期结果.
主要成果:
- 在SAKURA 1和SAKURA 2的治疗成功率为DAXI的74%,而安慰剂的0%在第4周.
- 在三个周期中,SAKURA 3 显示了持续的疗效,治疗成功率分别为 73.2%,77.7% 和 79.6%.
- 推剂量是40个单位,通过5次肌内注射.
结论:
- 注射用达克西博胺毒素A在治疗中度至重度的 glabellar 线条方面表现出高效.
- 新型配方可能有助于其有效性和持续时间.
- 达西提供了一种新的治疗选择,用于改善 glabellar线的美学效果.
更多相关视频
10:57Intramuscular Injections Along the Motor End Plates: A Minimally Invasive Approach to Shuttle Tracers Directly into Motor Neurons
Published on: July 13, 2015
09:38Dithranol as a Matrix for Matrix Assisted Laser Desorption/Ionization Imaging on a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer
Published on: November 26, 2013
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
The binding of dantrolene to the RYR1...
Skeletal Muscle Relaxants: Therapeutic Uses
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Depolarizing Blockers: Pharmocokinetics
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
